Optimisation of lupus anticoagulant tests: Should test samples always be mixed with normal plasma?

Thrombosis and Haemostasis

Volumn 112, Issue 4, 2014, Pages 736-742

  Pennings, Maarten T T ^a   de Groot, Philip G ^a   Meijers, Joost C M ^b,c   Huisman, Albert ^a   Derksen, Ronald H W M ^a   Urbanus, Rolf T ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c SANQUIN RESEARCH   (Netherlands)

Author keywords

Coagulation factor deficiency; Lupus anticoagulant; Mixing test; Vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; HIGH MOLECULAR WEIGHT KININOGEN; LUPUS ANTICOAGULANT; PREKALLIKREIN; PROTHROMBIN; VITAMIN K GROUP;

ARTICLE; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CLINICAL ARTICLE; COAGULATION FACTOR DEFICIENCY; CONTROLLED STUDY; FALSE POSITIVE RESULT; HUMAN; MEASUREMENT PRECISION; MEASUREMENT REPEATABILITY; PROCESS OPTIMIZATION; RELIABILITY; RUSSELL VIPER VENOM TIME; SILICA CLOTTING TIME; ANTAGONISTS AND INHIBITORS; ANTIPHOSPHOLIPID SYNDROME; BLOOD; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; DEVICES; DIAGNOSTIC PROCEDURE; FEMALE; IMMUNOLOGY; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; PREGNANCY; PROCEDURES;

ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CLINICAL LABORATORY TECHNIQUES; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LUPUS COAGULATION INHIBITOR; PREGNANCY; VITAMIN K;

EID: 84908512122     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-02-0122     Document Type: Article

References (16)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-1832.
3. de Groot PG, Lutters B, Derksen RH, et al. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost 2005; 3: 1993-1997.
4. Urbanus RT, Siegerink B, Roest M, et al. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
5. Ruffatti A, Del Ross T, Ciprian M, et al. Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. Ann Rheum Dis 2011; 70: 1083-1086.
6. Lockshin MD, Kim M, Laskin CA, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012; 64: 2311-2318.
7. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7: 1737-1740.
8. Exner T, Triplett DA, Taberner D, et al. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991; 65: 320-322.
9. Devreese KM. No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants? J Thromb Haemost 2010; 8: 1120-1122.
10. Favaloro EJ, Bonar R, Zebeljan D, et al. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost 2010; 8: 2828-2831.
11. Tripodi A, Pengo V. More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost 2011; 9: 2126-2127.
12. Tripodi A. To mix or not to mix in lupus anticoagulant testing? That is the question. Semin Thromb Hemost 2012; 38: 385-389.
13. McGlasson DL, Fritsma GA. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits. Semin Thromb Hemost 2013; 39: 315-319.
14. Chantarangkul V, Biguzzi E, Asti D, et al. Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant. Thromb Haemost 2013; 110: 46-52.
15. Tripodi A, Chantarangkul V, Clerici M, et al. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost 2002; 88: 583-586.
16. Schleider MA, Nachman RL, Jaffe EA, et al. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509.